Panel: Inside the investor’s mind: What fundable companies look like in 2026
09 Feb 2026
Indigo Ballroom, Hilton Bayfront Hotel
Investment Summit
Key takeaways
-
Define the scientific and operational milestones investors expect before committing capital
-
Examine how early human data and translational proof influence investor confidence
-
Assess how manufacturing readiness and scalability impact funding decisions
-
Explore the role of regulatory clarity and reimbursement strategy in determining company value
-
Identify practical steps biotech founders can take to align with investor priorities